Condition
Liver Neoplasm clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Liver Neoplasm clinical trials that are recruiting, at sites in 6 countries (most in China (2), United States (2), Australia (1)). By phase: Phase 1/2 (1), Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 6Countries
Newest Liver Neoplasm clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Variability in microwave ablation size for liver tumors | — | Vandœuvre-lès-Nancy | Recruiting | Feb 17, 2026 |
| Predicting heart injury after major liver and biliary surgery | — | Beijing and 5 other locations | Recruiting | Jan 12, 2026 |
| Single-cell and spatial mapping of liver degeneration and regeneration | — | Guangzhou, Guangdong | Recruiting | Dec 5, 2025 |
| Using contrast-enhanced ultrasound to check Y-90 radioembolization response in liver cancer | Phase 2 | Philadelphia, Pennsylvania | Recruiting | Aug 28, 2025 |
| Combining DEBIRI with chemotherapy for colorectal cancer liver metastases | Phase 3 | Tehran, Tehran Province | Recruiting | Aug 15, 2024 |
| Using contrast agents to improve liver cancer radiation therapy | — | Waratah, New South Wales and 4 other locations | Recruiting | Dec 23, 2021 |
| T-Cell Therapy for Advanced Liver Cancer | Phase 1/2 | Duarte, California and 7 other locations | Recruiting | Apr 28, 2021 |
All recruiting trials (7)
-
Variability in microwave ablation size for liver tumors
This project will see if patient and tumor features change the size and shape of microwave ablation zones in adults treated for liver tumors.
-
Predicting heart injury after major liver and biliary surgery
We test whether a stepwise prediction model using routine clinical data, the type and timing of liver blood-flow control (SPVO vs Pringle), and simple blood markers can predict heart injury (MINS) after major hepatobiliary surgery in adults.
-
Single-cell and spatial mapping of liver degeneration and regeneration
This project will try to use single-cell and spatial omics on preoperative blood and discarded liver tissue from people having liver surgery or biopsy to map how cells change during fatty liver, HBV infection, fibrosis, and cirrhosis.
-
Using contrast-enhanced ultrasound to check Y-90 radioembolization response in liver cancer
This will test whether contrast-enhanced ultrasound (CEUS) can show treatment response to Y‑90 radioembolization in people with newly diagnosed hepatocellular carcinoma who are scheduled for TARE.
-
Combining DEBIRI with chemotherapy for colorectal cancer liver metastases
This study is testing if adding a special treatment called DEBIRI to regular chemotherapy can help patients with colorectal cancer that has spread to the liver feel better and possibly have surgery later.
-
Using contrast agents to improve liver cancer radiation therapy
This study is testing if using special contrast agents can help doctors better track liver tumors during radiation therapy for patients who have already received a different treatment.
-
T-Cell Therapy for Advanced Liver Cancer
This study is testing a new T-cell therapy to see if it can help adults with advanced liver cancer that has a specific marker called GPC3.
Related topics
Quick answers
How many Liver Neoplasm clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (2 trials), United States (2 trials), Australia (1 trial), France (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.